Edwards Lifesciences (NYSE:EW) reported quarterly earnings results on February 10, 2026 that fell short of analyst expectations. The Healthcare company reported earnings per share…
Edwards Lifesciences (NYSE:EW) reported quarterly earnings results on February 10, 2026 that fell short of analyst expectations.
The Healthcare company reported earnings per share of $0.58, missing the consensus estimate of $0.62 by $0.04 per share. Revenue came in at $1.6B, beating the estimate of $1.5B.
Edwards Lifesciences's stock moved following the earnings release. The stock currently trades at $75.14 with a market capitalization of $49.5B.
Current market data
NYSE · EW
$91.60
Down: -$0.96 · -1.04%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
earnings ·
institutional ·
analyst ·
analyst ·
